Aliment Pharm Ther
10.1016/j.omtm.2024.101207 22 LingH.ZhuZ.YangJ.HeJ.YangS.WuD.et al (2018)
When Compounded May Be Appropriate According to federal guidelines and the company's disclosures, compounded tirzepatide may be appropriate when: Insurance denies coverage, and you cannot afford $1,000+/month out-of-pocket for brand-name Brand-name medications are unavailable due to shortages You meet medical criteria (BMI 30+ or 27+ with comorbidities) but cannot access FDA-approved options Your prescriber determines that the compounded preparation offers meaningful access where approved products are not feasible for you The evaluating clinician determines whether compounded tirzepatide is appropriate based on individual health factors, access barriers, and medical necessity
The peptide supports healing but cannot override continued tissue damage from premature loading
The same is true for women with irregular periods, those on hormonal medications, postmenopausal women, or those taking blood thinners
If glutathione levels drop, the removal of heavy metals slows down, leading to their buildup